BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30191971)

  • 1. The prognostic and therapeutic values of long noncoding RNA PANDAR in colorectal cancer.
    Rivandi M; Pasdar A; Hamzezadeh L; Tajbakhsh A; Seifi S; Moetamani-Ahmadi M; Ferns GA; Avan A
    J Cell Physiol; 2019 Feb; 234(2):1230-1236. PubMed ID: 30191971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.
    Liu J; Ben Q; Lu E; He X; Yang X; Ma J; Zhang W; Wang Z; Liu T; Zhang J; Wang H
    Cell Death Dis; 2018 Feb; 9(2):168. PubMed ID: 29416011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
    Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
    J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer.
    Ma P; Xu T; Huang M; Shu Y
    Biomed Pharmacother; 2016 Mar; 78():172-176. PubMed ID: 26898439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding PANDAR as a novel biomarker in human cancer: A systematic review.
    Zou Y; Zhong Y; Wu J; Xiao H; Zhang X; Liao X; Li J; Mao X; Liu Y; Zhang F
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
    Ai X; Lei Q; Shen X; Li J; Cen C; Xie G; Luo B; Zhu W; Hu G; Wu H; Chen M; Li X; Lin C
    Oncol Rep; 2019 Jan; 41(1):483-491. PubMed ID: 30542703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT.
    Rezanejad Bardaji H; Asadi MH; Yaghoobi MM
    Eur J Cell Biol; 2018 May; 97(4):279-288. PubMed ID: 29656793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
    Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
    Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 19. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNAs as Prognostic Markers for Colorectal Cancer in Saudi Patients.
    Siddique H; Al-Ghafari A; Choudhry H; AlTurki S; Alshaibi H; Al Doghaither H; Alsufiani H
    Genet Test Mol Biomarkers; 2019 Aug; 23(8):509-514. PubMed ID: 31328973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.